ALVOTECH
Alvotech is a fully integrated specialty biopharmaceutical company focused exclusively on the development and manufacture of high-quality biosimilar medicines. The company's goal is to improve patients' health and quality of life around the world by increasing access to effective therapies for various ailments. Alvotech was established on January 1, 2013, by Róbert Wessman in Reykjavík, Gullbringusysla.
ALVOTECH
Industry:
Biotechnology Life Science Pharmaceutical
Founded:
2013-01-01
Address:
Reykjavík, Gullbringusysla, Iceland
Country:
Iceland
Website Url:
http://www.alvotech.com
Total Employee:
501+
Status:
Active
Contact:
+354 422 4500
Email Addresses:
[email protected]
Total Funding:
1.72 B USD
Technology used in webpage:
Domain Not Resolving IPv6 U.S. Server Location CrUX Top 10m DigiCert SSL Akamai Hosted
Similar Organizations
Core Biogenesis
Core Biogenesis is a biotechnology company building next-generation recombinant protein production technologies.
Gritstone Bio
Gritstone Oncology is a clinical-stage biotech company that develops tumor-specific cancer immunotherapies to fight multiple cancer types.
Iroko Pharmaceuticals
Iroko Pharmaceuticals is a global specialty pharmaceutical company dedicated to advancing the science of analgesia.
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
Ocean Biomedical
Ocean Biomedical is a biotechnology company that accelerates new discoveries in the world of medicine.
Syros Pharmaceuticals
Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.
VintaBio
VintaBio is a life sciences company that offers cell and gene therapy manufacturing services.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2016-05-19 | Baliopharm | Baliopharm acquired by Alvotech | N/A |
Investors List
Alvogen
Alvogen investment in Venture Round - Alvotech
Athos Capital
Athos Capital investment in Venture Round - Alvotech
Shinhan Capital
Shinhan Capital investment in Venture Round - Alvotech
Baxter Ventures
Baxter Ventures investment in Venture Round - Alvotech
Aztiq
Aztiq investment in Venture Round - Alvotech
Fuji Pharma
Fuji Pharma investment in Corporate Round - Alvotech
Key Employee Changes
| Date | New article |
|---|---|
| 2024-02-29 | Alvotech Appoints Interim Chief Quality Officer |
| 2022-10-11 | Alvotech Appoints Sarah Tanksley as Chief Quality Officer |
Official Site Inspections
http://www.alvotech.com Semrush global rank: 3.3 M Semrush visits lastest month: 4.27 K
- Host name: 76.76.21.22
- IP address: 76.76.21.22
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Alvotech"
Company - Alvotech - Better Access Better Lives
Working for Alvotech. Moving to Iceland. Job openings. Company News. Media Gallery. Skip Navigation. About us. Creating a healthier world through affordable biologics. Who we are. We have a deep appreciation for the positive impact …See details»
Leadership - Alvotech - Better Access Better Lives
Alvotech brings together a group of senior pharmaceutical executives with broad backgrounds and extensive experience in the biopharmaceutical industry. 01 Company. About us. Culture …See details»
Org Chart Alvotech - The Official Board
Organizational Chart of Alvotech. Alvotech www.alvotech.com. has 27 executives - and belongs to Alvogen +354 522 2900; Add an executive. Alvotech News . Anything missing? We search for you. Print or download . Board. N-1. N-2 . …See details»
Alvotech - Crunchbase Company Profile & Funding
Alvotech and Advanz Pharma signed a commercialization agreement for a proposed biosimilar to Eylea® LD/HD in Europe. Analysts expect Alvotech to reach breakeven soon. Alvotech …See details»
Alvotech - Overview, News & Similar companies | ZoomInfo.com
May 24, 2024 Alvotech is a privately-owned biopharmaceutical company focused on the development and manufacturing of high quality biosimilars for global markets. They are …See details»
Alvotech - Funding, Financials, Valuation & Investors - Crunchbase
Alvotech is a biotechnology company that specializes in making biosimilars to create biologic medicines. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. ... Which …See details»
Alvotech - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Alvotech . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. ... Alvotech has 1 board member or advisor, …See details»
Financial Information | Alvotech
The Investor Relations website contains information about Alvotech's business for stockholders, potential investors, and financial analysts.See details»
ESG Portal - Alvotech - Better Access Better Lives
Alvotech is committed to the promise of biosimilars, which we believe can directly expand patient access to medicines globally and contribute to the overall sustainability of healthcare systems by providing lower cost alternatives to …See details»
Alvotech Reports Financial Results for Full Year 2023 and Provides …
In 2023, an impairment of $21.5 million was recognized on the joint venture investment based on discussions between Alvotech and CCHN to buy back Alvotech's interests in the joint venture. …See details»
Alvotech Expands its Board of Directors as part of Transition from ...
Jul 14, 2022 Following the debut of Alvotech as a publicly traded company, the largest Icelandic company to make its debut on a U.S. stock exchange, Alvotech was also listed on the Nasdaq …See details»
Alvotech - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Nov 10, 2024 Alvotech uses 18 technology products and services including HTML5, Microsoft Outlook, and Office 365, according to G2 Stack. Alvotech is actively using 47 technologies for …See details»
Office locations - Alvotech - Better Access Better Lives
Alvotech’s international team currently includes over 400 scientists and professionals. Alvotech’s international team currently includes over 400 scientists and professionals. 01 Company. …See details»
Alvotech: Culture - LinkedIn
Alvotech will connect patients all around the world with new biopharmaceuticals. We nurture a positive working environment by hiring a talented team of innovative people.See details»
Alvotech to Report Financial Results for the First Nine Months of …
REYKJAVIK, Iceland, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar …See details»
Our culture - Alvotech - Better Access Better Lives
At Alvotech, we specialize in biosimilars and love what we do. We are a team of over 1000 professionals, living and working in multiple countries, united by our commitment to improving …See details»
Alvotech's Position In The Coming Biosimilar Gold Rush
Nov 21, 2024 Alvotech's first nine months of 2024 financial results reflect the strengths and challenges of the company's aggressive market expansion while reducing costs. As of …See details»
Culture - Alvotech - Better Access Better Lives
Alvotech prides itself on attracting highly experienced industry talent, drawn by its purpose-driven culture. With its strong emphasis on excellence and commitment to improving the lives of …See details»
Alvotech Reports Financial Results for the First Nine Months of …
Nov 13, 2024 Alvotech will conduct a business update conference call and live webcast on Thursday, November 14, 2024, at 8:00 am ET (13:00 GMT) REYKJAVIK, Iceland, Nov. 13, …See details»